NeurAxis PENFS IB-Stim Technology: A Drug-Free, Non-Invasive

NeurAxis Inc. proves that a smallcap biotech can deliver best-in-market care. That's more than great news for NRXS from a revenue perspective and for its patients from a treatment point of view. It...

Related Keywords

Boston , Massachusetts , United States , Rob Goldman , Jack Enterprises , Hawk Point Media Group Llc , Neuraxis Inc , Boston Scientific Corp , Goldman Smallcap Research , Functional Abdominal Pain , Irritable Bowel Syndrome , Smallcap Research , Immediate Post Concussion Assessment , Post Concussion Symptom Scale , Balance Error Scoring Symptom , Big Pharma , Point Media Group , Eyed Jack Enterprises , Private Securities Litigation Reform Act , Hawk Point , Markets ,